AXIM Biotechnologies, Inc.

AXIM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
15-12G Dec 6, 2024 AXIM BIOTECHNOLOGIES, INC. FORM 15-12G
NT 10-Q Nov 13, 2024 AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q
4 Oct 15, 2024 PRIMARY DOCUMENT
8-K Oct 15, 2024 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
10-Q Aug 19, 2024 FORM 10-Q
NT 10-Q Aug 13, 2024 AXIM BIOTECHNOLOGIES FORM 12B-25
10-Q/A May 22, 2024 FORM 10-Q/A
10-Q May 20, 2024 FORM 10-Q
NT 10-Q May 15, 2024 AXIM BIOTECHNOLOGIES FORM 12B-25
10-K Apr 16, 2024 FORM 10-K
NT 10-K Apr 1, 2024 AXIM BIOTECHNOLOGIES, INC. - NT 10K
8-K Mar 21, 2024 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
4/A Mar 19, 2024 PRIMARY DOCUMENT
4 Mar 19, 2024 PRIMARY DOCUMENT
4 Mar 19, 2024 PRIMARY DOCUMENT
4 Mar 19, 2024 PRIMARY DOCUMENT
4 Mar 19, 2024 PRIMARY DOCUMENT
4 Mar 19, 2024 PRIMARY DOCUMENT
4 Mar 19, 2024 PRIMARY DOCUMENT
4 Mar 19, 2024 PRIMARY DOCUMENT
8-K Feb 13, 2024 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
8-K Dec 28, 2023 AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING
10-Q Nov 20, 2023 FORM 10-Q
NT 10-Q Nov 14, 2023 AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q
DEF 14C Sep 21, 2023 AXIM BIOTECHNOLOGIES, INC. - DEF14C
← Newer Page 1 of 13 · 306 filings Older →